Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

VTYX Ventyx Biosciences Inc

2,01

0,12 (6,35%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:12:15

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

SHARES TO BE SOLD TO COVER WITHHOLDING TAXES UPON VESTING OF RESTRICTED STOCK UNIT AWARDS

Date of Notice

12/19/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Austin Rutherford, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Ventyx Biosciences Charts.

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Ventyx Biosciences Charts.

News Ventyx Biosciences Inc

Form 8-K - Current report
Dienstag 14 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
Dienstag 14 Januar 2025 (3 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 30 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 27 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 20 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Ventyx Biosciences Inc News-Artikel

Gold vs US Dollar

JP Morgan Chase

Deutsche Telekom

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Health Care Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen